Evolent Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Evolent Health
EVH Stock  USD 2.79  0.02  0.72%   
Evolent Health's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Evolent Health's valuation are provided below:
Gross Profit
378.3 M
Profit Margin
(0.06)
Market Capitalization
321.2 M
Enterprise Value Revenue
0.6206
Revenue
2.1 B
We have found one hundred twenty available fundamental signals for Evolent Health, which can be analyzed and compared to other ratios and to its rivals. Traders should compare all of Evolent Health prevailing fundamentals against the fundamentals between 2010 and 2026 to make sure the company is sustainable this year. The current Market Cap is estimated to decrease to about 732.6 M. Enterprise Value is estimated to decrease to about 681.3 M

Evolent Health Total Revenue

3.08 Billion

Check Evolent Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Evolent Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 148.7 M, Total Revenue of 3.1 B or Gross Profit of 443.6 M, as well as many indicators such as Price To Sales Ratio of 0.55, Dividend Yield of 0.0072 or PTB Ratio of 1.22. Evolent financial statements analysis is a perfect complement when working with Evolent Health Valuation or Volatility modules.
  
Build AI portfolio with Evolent Stock
Check out the analysis of Evolent Health Correlation against competitors.
For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.

Evolent Health Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets3.1 B2.9 B1.3 B
Slightly volatile
Other Current Liabilities505.7 M481.6 M204.9 M
Slightly volatile
Total Current Liabilities864 M822.8 M299.2 M
Slightly volatile
Property Plant And Equipment Net84.9 M91.2 M66 M
Slightly volatile
Accounts Payable116 M110.4 M50.6 M
Slightly volatile
Cash171 M119.8 M136.6 M
Slightly volatile
Non Current Assets Total2.3 B2.2 B982 M
Slightly volatile
Other Assets58.4 M36.7 M46.5 M
Slightly volatile
Cash And Short Term Investments194.4 M188 M157 M
Slightly volatile
Net Receivables500.7 M476.9 M157.4 M
Slightly volatile
Common Stock Shares Outstanding77.9 M131.9 M71 M
Slightly volatile
Liabilities And Stockholders Equity3.1 B2.9 B1.3 B
Slightly volatile
Other Current Assets54.6 M33.3 M43.2 M
Slightly volatile
Total Liabilities1.9 B1.8 B659.6 M
Slightly volatile
Total Current Assets378.6 M698.2 M327.4 M
Slightly volatile
Intangible Assets821.3 M782.2 M314 M
Slightly volatile
Other Liabilities71.7 M63.8 M53.4 M
Slightly volatile
Current Deferred Revenue2.1 M2.3 M13 M
Slightly volatile
Short Term Investments71.6 M68.2 M26.9 M
Slightly volatile
Non Current Liabilities Total999.4 M951.8 M365 M
Slightly volatile
Property Plant And Equipment Gross153 M298 M119.8 M
Slightly volatile
Short Term Debt239.3 M227.9 M80.9 M
Slightly volatile
Property Plant Equipment65.6 M91.2 M53.8 M
Slightly volatile
Good Will756.5 M1.3 B709.7 M
Slightly volatile
Common Stock Total Equity791.4 K1.2 M615.7 K
Slightly volatile
Deferred Long Term Liabilities4.1 M4.3 M12 M
Slightly volatile
Long Term Investments7.3 M7.7 M26.2 M
Slightly volatile
Common Stock879.5 K1.3 M648.2 K
Slightly volatile
Noncontrolling Interest In Consolidated Entity5.7 M6 M120.8 M
Slightly volatile
Capital Surpluse1.3 B2.1 B990.3 M
Slightly volatile
Non Current Liabilities Other3.3 M3.4 M23 M
Slightly volatile
Short and Long Term Debt Total419.1 M820.7 M317.1 M
Slightly volatile
Long Term Debt Total334.4 M564.1 M256.2 M
Slightly volatile
Short and Long Term Debt120.9 M197.2 M120.4 M
Slightly volatile
Cash And Equivalents157.6 M93.8 M166.6 M
Pretty Stable
Net Invested Capital1.4 B1.9 B1.3 B
Slightly volatile
Capital Stock1.1 M1.3 M927.1 K
Slightly volatile
Capital Lease Obligations49.6 M46.5 M67.3 M
Slightly volatile

Evolent Health Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization148.7 M141.6 M54.1 M
Slightly volatile
Total Revenue3.1 B2.9 B939.9 M
Slightly volatile
Other Operating Expenses3.1 B3 B1 B
Slightly volatile
Cost Of Revenue2.6 B2.5 B746.9 M
Slightly volatile
Selling General Administrative241.1 M302.5 M189.4 M
Slightly volatile
Research Development18.3 M30.7 M15.5 M
Slightly volatile
Non Recurring197.3 M247.4 M190.8 M
Slightly volatile
Interest Income4.9 M5 M12.4 M
Slightly volatile
Reconciled Depreciation78.1 M136.1 M59.4 M
Slightly volatile
Selling And Marketing Expenses102.6 M90.1 M132.8 M
Slightly volatile

Evolent Health Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation48 M45.7 M20.3 M
Slightly volatile
Begin Period Cash Flow230 M257 M183.1 M
Slightly volatile
Depreciation151.7 M144.5 M53.6 M
Slightly volatile
Capital Expenditures25 M28.6 M20.8 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.550.5818.5363
Slightly volatile
Dividend Yield0.00720.0140.0123
Slightly volatile
Days Sales Outstanding76.868.1373.3452
Slightly volatile
Stock Based Compensation To Revenue0.0170.01790.0385
Pretty Stable
Capex To Depreciation0.220.234.5462
Slightly volatile
EV To Sales0.810.8618.1703
Slightly volatile
Payables Turnover21.5320.512.1092
Slightly volatile
Sales General And Administrative To Revenue0.260.280.4702
Slightly volatile
Research And Ddevelopement To Revenue0.02180.0230.0417
Slightly volatile
Capex To Revenue0.01060.01120.1031
Slightly volatile
Cash Per Share2.731.642.2426
Pretty Stable
Days Payables Outstanding17.5118.4356.2227
Slightly volatile
Intangibles To Total Assets0.40.640.4604
Slightly volatile
Current Ratio1.910.981.5841
Very volatile
Receivables Turnover4.75.545.4817
Slightly volatile
Debt To Equity0.340.640.3381
Slightly volatile
Capex Per Share0.250.20.2703
Slightly volatile
Revenue Per Share21.0520.058.9271
Slightly volatile
Interest Debt Per Share6.085.792.9576
Slightly volatile
Debt To Assets0.160.250.1649
Slightly volatile
Graham Number50.3147.9240.9573
Slightly volatile
Days Of Payables Outstanding17.5118.4356.2227
Slightly volatile
Long Term Debt To Capitalization0.190.30.2101
Slightly volatile
Total Debt To Capitalization0.220.370.2337
Slightly volatile
Debt Equity Ratio0.340.640.3381
Slightly volatile
Quick Ratio1.930.981.5935
Very volatile
Net Income Per E B T0.961.120.9081
Pretty Stable
Cash Ratio0.160.170.9508
Slightly volatile
Days Of Sales Outstanding76.868.1373.3452
Slightly volatile
Fixed Asset Turnover30.4529.011.158
Slightly volatile
Debt Ratio0.160.250.1649
Slightly volatile
Price Sales Ratio0.550.5818.5363
Slightly volatile
Asset Turnover0.950.90.526
Slightly volatile

Evolent Health Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap732.6 M765.9 M682.3 M
Very volatile
Enterprise Value681.3 M749.4 M657.2 M
Very volatile

Evolent Fundamental Market Drivers

Forward Price Earnings18.8679
Cash And Short Term Investments163.5 M

Evolent Upcoming Events

28th of February 2024
Upcoming Quarterly Report
View
1st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
28th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Evolent Health Financial Statements

Investors use fundamental indicators, such as Evolent Health's revenue or net income, to determine how well the company is positioned to perform in the future. Although Evolent Health's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Current Deferred Revenue2.3 M2.1 M
Total Revenue2.9 B3.1 B
Cost Of Revenue2.5 B2.6 B
Stock Based Compensation To Revenue 0.02  0.02 
Sales General And Administrative To Revenue 0.28  0.26 
Research And Ddevelopement To Revenue 0.02  0.02 
Capex To Revenue 0.01  0.01 
Revenue Per Share 20.05  21.05 
Ebit Per Revenue(0.01)(0.01)

Currently Active Assets on Macroaxis

FSLYFastly Class A
MOBMobilicom Limited American
CMGChipotle Mexican Grill
CSANCosan SA ADR
RKTRocket Companies
When determining whether Evolent Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Evolent Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Evolent Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Evolent Health Stock:
How To Invest In Evolent
Details
Is Evolent Stock a good investment?
Details
What is Evolent Health's Net Worth?
Details
Largest Health Care Technology Companies
View
Largest Health Care Equipment & Services Companies
View
Check out the analysis of Evolent Health Correlation against competitors.
For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.
You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is there potential for Health Care Technology market expansion? Will Evolent introduce new products? Factors like these will boost the valuation of Evolent Health. Projected growth potential of Evolent fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Evolent Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.58)
Revenue Per Share
17.85
Quarterly Revenue Growth
(0.23)
Return On Assets
0.0012
Return On Equity
(0.12)
Understanding Evolent Health requires distinguishing between market price and book value, where the latter reflects Evolent's accounting equity. The concept of intrinsic value - what Evolent Health's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Evolent Health's price substantially above or below its fundamental value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
It's important to distinguish between Evolent Health's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Evolent Health should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Evolent Health's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY